Iman Jodeh
- Democratic
- Senator
- District 29
Primary
Beginning July 1, 2025 No later than January 1, 2026 , the bill requires the department of health care policy and financing (HCPF) to seek federal authorization to reimburse acute care hospitals and ambulatory surgery facilities that provide vagus nerve stimulation therapy to members diagnosed with drug-resistant epilepsy at a rate that is equal to 75% 60% of the cost for acquiring the vagus nerve stimulator device, which reimbursement is in addition to and does not supplant the reimbursement for any necessary surgical procedure associated with implanting the device. Beginning January 1, 2029, the bill requires HCPF to increase the reimbursement to a rate that is equal to 75% of the cost for acquiring the vagus nerve simulator device. (Note: Italicized words indicate new material added to the original summary; dashes through words indicate deletions from the original summary.) (Note: This summary applies to the reengrossed version of this bill as introduced in the second house.)
Introduced In House - Assigned to Health & Human Services
Senate Third Reading Passed - No Amendments
Senate Second Reading Special Order - Passed with Amendments - Committee
Senate Committee on Appropriations Refer Amended - Consent Calendar to Senate Committee of the Whole
Senate Committee on Health & Human Services Refer Amended to Appropriations
Introduced In Senate - Assigned to Health & Human Services
| Bill Text Versions | Format |
|---|---|
| Reengrossed (04/23/2025) | |
| Engrossed (04/22/2025) | |
| Introduced (02/04/2025) | |
| PA2 (04/22/2025) | |
| PA1 (02/21/2025) | |
| Committee Amendment |
| Document | Format |
|---|---|
| Fiscal Note SA1 (04/17/2025) | |
| Fiscal Note FN1 (02/18/2025) | |
| Fiscal Note FN2 (02/28/2025) | |
| Fiscal Note MEMO1 (04/22/2025) | |
| Fiscal Note FN3 (04/24/2025) | |
| Fiscal Note FN4 (05/21/2025) |
Data on Open States is updated periodically throughout the day from the official website of the Colorado General Assembly.
If you notice any inconsistencies with these official sources, feel free to file an issue.